Christopher M. Bral
Impact in
-
- Chronic Kidney Disease and Diabetes
- Acute Kidney Injury Research
-
- Carcinogens and Genotoxicity Assessment
Papers in
-
- Genomics, phytochemicals, and oxidative stress 2
- Peroxisome Proliferator-Activated Receptors 1
-
- Eicosanoids and Hypertension Pharmacology 1
- Co-authors
- Kenneth S. Ramos (6 shared papers)Alan Parrish (3 shared papers)Robert C. Burghardt (1 shared paper)Robyn L. Fisher (1 shared paper)Ira Rosenblum (1 shared paper)Klaus Brendel (1 shared paper)Nathaniel D. Collins (1 shared paper)Leslie Obert (1 shared paper)
- Journals
- Biochemical Pharmacology (2 papers)Toxicology and Applied Pharmacology (2 papers)Atherosclerosis (1 paper)Molecular Pharmacology (1 paper)In Vitro Cellular & Developmental Biology - Animal (1 paper)
- Partner nations
- United States
In The Last Decade
Christopher M. Bral
9 papers receiving 187 citations
Peers
Comparison fields: 5 of 55
- Nephrology 25
- Cancer Research 46
- Pharmacology 26
- Health, Toxicology and Mutagenesis 36
- Biochemistry 17
Countries citing papers authored by Christopher M. Bral
This map shows the geographic impact of Christopher M. Bral's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. Bral with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. Bral more than expected).
Fields of papers citing papers by Christopher M. Bral
This network shows the impact of papers produced by Christopher M. Bral. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. Bral. The network helps show where Christopher M. Bral may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher M. Bral, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 54 | |
| 2 | 1997 | 42 | |
| 3 | 1998 | 39 | |
| 4 | 2000 | 21 | |
| 5 | 2002 | 17 | |
| 6 | 2002 | 9 | |
| 7 | 2007 | 7 | |
| 8 | 1996 | 6 | |
| 9 | RNA polymerase II transcription complex assembly in nuclear extracts. | 1998 | 6 |
About Christopher M. Bral
Christopher M. Bral is a scholar working on Molecular Biology, Biochemistry, Cancer Research, Health, Toxicology and Mutagenesis and Genetics, having authored 9 papers that have together received 201 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers), Toxic Organic Pollutants Impact (2 papers), Carcinogens and Genotoxicity Assessment (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Retinal Diseases and Treatments (1 paper). The work is most often cited by research in Nephrology (25 citations), Cancer Research (46 citations), Pharmacology (26 citations), Health, Toxicology and Mutagenesis (36 citations) and Biochemistry (17 citations). Christopher M. Bral has collaborated with scholars based in United States. Frequent co-authors include Kenneth S. Ramos, Alan Parrish, Robert C. Burghardt, Robyn L. Fisher, Ira Rosenblum, Klaus Brendel, Nathaniel D. Collins, Leslie Obert, C. Edwin Garner and Federico Goodsaid. Their work appears in journals such as Biochemical Pharmacology, Toxicology and Applied Pharmacology, Atherosclerosis, Molecular Pharmacology and In Vitro Cellular & Developmental Biology - Animal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.